Unknown
Dubai, United Arab Emirates (CNN) - approved by the Food
And Drug Administration, FDA, outlines the development and experience
Artificial pancreas to treat diabetes type one. This
Steps will be made available to researchers and manufacturers some flexibility
In order to obtain safe and effective tool for patients as soon as
Possible.
Zmlik says Charles Shipp, President of the researchers in this area
Within the organization: "flexibility in dealing with this device is a
The most important labels in these lines, the main objective is to transfer the experience
Clinical outpatient to learn how to work in
The real world, not just the pilot. "
Despite the artificial pancreas to name it, can not be considered
Device, offsetting enough for this important member in the body,
The responsibility for the secretion of insulin. Instead, it will be used
Device of two parts, one of the insulin pump, and the other control device
Continuous glucose, together carrying out the function of the pancreas, with control
Constant level of sugar in the blood through the index that is installed under the
The skin.
This department is working to control the level of glucose (sugar
Blood), in the event of increased or decreased sharply, the pump works programmed
To modify the dose of insulin immediately to return the percentage of sugar in the blood to
Natural.
If approved these devices, there is great hope
Improve the living conditions of more than three million people in the UnitedStates
Who suffer from diabetes type I, who are supposed
Be controlled blood sugar levels have steadily during the day
And inject insulin whenever needed it.
According Zmlik, the supervisor of the study, results in a promising future
For this type of treatments, and the guidelines that have been approved
It includes how to start testing and see a very encouraging
Basis of the number of patients applied to them, and the length of the experiment and the target
Them. The FDA encouraged the manufacturers to innovate in the manufacturing of these
Devices in line with more patient comfort.
